GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngen Biotech Co Ltd (ROCO:8279) » Definitions » Gross-Profit-to-Asset %

Syngen Biotech Co (ROCO:8279) Gross-Profit-to-Asset % : 21.03% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Syngen Biotech Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Syngen Biotech Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was NT$660 Mil. Syngen Biotech Co's average Total Assets over the quarter that ended in Mar. 2024 was NT$3,138 Mil. Therefore, Syngen Biotech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 21.03%.


Syngen Biotech Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Syngen Biotech Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngen Biotech Co Gross-Profit-to-Asset % Chart

Syngen Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.10 24.43 23.26 25.09 20.85

Syngen Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.83 20.45 21.51 20.14 21.03

Competitive Comparison of Syngen Biotech Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Syngen Biotech Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngen Biotech Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngen Biotech Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Syngen Biotech Co's Gross-Profit-to-Asset % falls into.



Syngen Biotech Co Gross-Profit-to-Asset % Calculation

Syngen Biotech Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=643.918/( (3070.875+3106.253)/ 2 )
=643.918/3088.564
=20.85 %

Syngen Biotech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=659.772/( (3106.253+3169.562)/ 2 )
=659.772/3137.9075
=21.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Syngen Biotech Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Syngen Biotech Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngen Biotech Co (ROCO:8279) Business Description

Traded in Other Exchanges
N/A
Address
Building A, NO.154, Kai-Yuan Road, Xinying District, Tainan, TWN, 73055
Syngen Biotech Co Ltd is a biotechnology company. It is engaged in the manufacturing, sales, and trading of microbial pharmaceutical raw materials. It also provides the design and development of health food and biochemical nutrition. The company's products include pharmaceutical ingredients, nutritional ingredients, biology fermentation products, biology agriculture and aquaculture products.

Syngen Biotech Co (ROCO:8279) Headlines

No Headlines